NfL levels in CSF were investigated in a longitudinal cohort of de novo PD patients (DeNoPa), demonstrating the highest levels in other neurodegenerative diseases including MSA and DLB compared to PD and the lowest levels in controls [56]. This evidence concerns the gene NEFL and Lewy body dementia.